TY - JOUR
T1 - Life course trajectories of cardiovascular risk
T2 - Impact on atherosclerotic and metabolic indicators
AU - Pollock, Benjamin D.
AU - Stuchlik, Patrick
AU - Harville, Emily W.
AU - Mills, Katherine T.
AU - Tang, Wan
AU - Chen, Wei
AU - Bazzano, Lydia A.
N1 - Publisher Copyright:
© 2018 Elsevier B.V.
PY - 2019/1
Y1 - 2019/1
N2 - Background and aims: In this analysis, we estimated population-level trajectory groups of life course cardiovascular risk to explore their impact on mid-life atherosclerotic and metabolic outcomes. Methods: This prospective study followed n = 1269 Bogalusa Heart participants, each with at least 4 study visits from childhood in 1973 through adulthood in 2016. We used discrete mixture modeling to determine trajectories of cardiovascular risk percentiles from childhood to adulthood. Outcomes included mid-life subclinical atherosclerotic measures [(carotid intima-media thickness (cIMT), pulse wave velocity (PWV)], metabolic indicators [(diabetes and body mass index (BMI)], and short physical performance battery (SPPB). Results: Between the mean ages of 9.6–48.3 years, we estimated five distinct trajectory groups of life course cardiovascular risk (High-Low, High-High, Mid-Low, Low-Low, and Low-High). Adult metabolic and vascular outcomes were significantly determined by life course cardiovascular risk trajectory groups (all p < 0.01). Those in the High-Low group had lower risks of diabetes (20% vs. 28%, respectively; p =.12) and lower BMIs (32.4 kg/m2 vs. 34.6 kg/m2; p =.06) than those who remained at high risk (High-High) throughout life. However, the High-Low group had better cIMT (0.89 mm vs. 1.05 mm; p <.0001) and PWV (7.8 m/s vs. 8.2 m/s; p =.03) than the High-High group. For all outcomes, those in the Low-Low group fared best. Conclusions: We found considerable movement between low- and high-relative cardiovascular risk strata over the life course. Children who improved their relative cardiovascular risk over the life course achieved better mid-life atherosclerotic health despite maintaining relatively poor metabolic health through adulthood.
AB - Background and aims: In this analysis, we estimated population-level trajectory groups of life course cardiovascular risk to explore their impact on mid-life atherosclerotic and metabolic outcomes. Methods: This prospective study followed n = 1269 Bogalusa Heart participants, each with at least 4 study visits from childhood in 1973 through adulthood in 2016. We used discrete mixture modeling to determine trajectories of cardiovascular risk percentiles from childhood to adulthood. Outcomes included mid-life subclinical atherosclerotic measures [(carotid intima-media thickness (cIMT), pulse wave velocity (PWV)], metabolic indicators [(diabetes and body mass index (BMI)], and short physical performance battery (SPPB). Results: Between the mean ages of 9.6–48.3 years, we estimated five distinct trajectory groups of life course cardiovascular risk (High-Low, High-High, Mid-Low, Low-Low, and Low-High). Adult metabolic and vascular outcomes were significantly determined by life course cardiovascular risk trajectory groups (all p < 0.01). Those in the High-Low group had lower risks of diabetes (20% vs. 28%, respectively; p =.12) and lower BMIs (32.4 kg/m2 vs. 34.6 kg/m2; p =.06) than those who remained at high risk (High-High) throughout life. However, the High-Low group had better cIMT (0.89 mm vs. 1.05 mm; p <.0001) and PWV (7.8 m/s vs. 8.2 m/s; p =.03) than the High-High group. For all outcomes, those in the Low-Low group fared best. Conclusions: We found considerable movement between low- and high-relative cardiovascular risk strata over the life course. Children who improved their relative cardiovascular risk over the life course achieved better mid-life atherosclerotic health despite maintaining relatively poor metabolic health through adulthood.
KW - Atherosclerosis
KW - Epidemiological methods
KW - Life course cardiovascular risk
KW - Metabolic disease
KW - Trajectory analysis
UR - http://www.scopus.com/inward/record.url?scp=85056620425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056620425&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2018.11.008
DO - 10.1016/j.atherosclerosis.2018.11.008
M3 - Article
C2 - 30453117
AN - SCOPUS:85056620425
SN - 0021-9150
VL - 280
SP - 21
EP - 27
JO - Atherosclerosis
JF - Atherosclerosis
ER -